Literature DB >> 16504657

Hypoxanthine as a graft ischemia marker stimulates catalase activity in the renal vein during reperfusion in humans.

L Domański1, K Safranow, B Dołegowska, J Rózański, M Myślak, K Ciechanowski, K Jakubowska, V Dziedziejko, M Romanowski, T Sulikowski, J Sieńko, M Kamiński, M Ostrowski, M Domański, A Pawlik, M E Rać, D Chlubek.   

Abstract

BACKGROUND: The impairment of organ function derived from ischemia-reperfusion injury is still an important problem in solid organ transplantation. Cell alterations induced by ischemia prime the tissue for subsequent damage occurring during the reperfusion phase. Purine nucleotides and oxypurines are products of adenine nucleotide degradation. Reperfusion and reoxygenation are characterized by great production of reactive oxygen species and free radicals. On the contrary, superoxide dismutase, catalase, glutathione, and glutathione peroxidase are involved in protecting against free radicals. The aim of the study was to examine the correlation between concentrations of ischemia markers (hypoxanthine or inosine) and the activity of erythrocyte superoxide dismutase, catalase, or glutathione peroxidase. PATIENTS AND METHODS: The study included 40 renal transplant recipients. Before anastomosis of the kidney vessels with the recipient's iliac vessels, a "0" blood sample was taken from the iliac vein. Then, after anastomosis, the renal vein of the graft was cannulated and blood samples I, II, and III were obtained. The reperfusion of the transplanted kidney was measured with a thermovision camera ThermaCAM SC500.
RESULTS: The plasma concentrations of hypoxanthine and inosine increased in statistically significant fashion immediately after total tissue reperfusion (P < .0001). Catalase activity at 4 minutes after total tissue reperfusion correlated positively with hypoxanthine concentrations immediately after total tissue reperfusion (Rs = +0.49), 2 minutes after total tissue reperfusion (Rs = +0.47), and 4 minutes after total tissue reperfusion (Rs = +0.46). There were no statistically significant correlations between hypoxanthine or inosine concentrations or superoxide dismutase or glutathione peroxidase activities.
CONCLUSIONS: The results of the present study suggest that catalase activity may correlate with the concentration of hypoxanthine in the graft renal vein and other mediators of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16504657     DOI: 10.1016/j.transproceed.2005.11.083

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Evaluation of oxidant and antioxidant status in living donor renal allograft transplant recipients.

Authors:  Sunil Kumar; Ujjawal Sharma; Ashish Sharma; Deepesh B Kenwar; Sarbpreet Singh; Rajendra Prasad; Mukut Minz
Journal:  Mol Cell Biochem       Date:  2016-01-13       Impact factor: 3.396

2.  Applications of translational bioinformatics in transplantation.

Authors:  P Khatri; M M Sarwal; A J Butte
Journal:  Clin Pharmacol Ther       Date:  2011-06-29       Impact factor: 6.875

3.  Individualized Dosage of Tacrolimus for Renal Transplantation Patients Based on Pharmacometabonomics.

Authors:  Xiaoying He; Xi Yang; Xiaoting Yan; Mingzhu Huang; Zheng Xiang; Yan Lou
Journal:  Molecules       Date:  2022-05-30       Impact factor: 4.927

4.  Association between the perioperative antioxidative ability of platelets and early post-transplant function of kidney allografts: a pilot study.

Authors:  Barbara Dołęgowska; Wojciech Błogowski; Leszek Domański
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

5.  Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells.

Authors:  Hye-Myung Ryu; You-Jin Kim; Eun-Joo Oh; Se-Hyun Oh; Ji-Young Choi; Jang-Hee Cho; Chan-Duck Kim; Sun-Hee Park; Yong-Lim Kim
Journal:  J Cell Mol Med       Date:  2016-07-11       Impact factor: 5.310

6.  Association of Coronary Artery Disease and Metabolic Syndrome: Usefulness of Serum Metabolomics Approach.

Authors:  Ziwei Jing; Liwei Liu; Yingying Shi; Qiuzheng Du; Dingding Zhang; Lihua Zuo; Shuzhang Du; Zhi Sun; Xiaojian Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-24       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.